Marpai (MRAI) has released an update to notify the public and investors about an entry into a material definitive agreement.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Marpai, Inc. has renegotiated its purchase agreement with AXA S.A., adjusting the purchase price down by $3 million contingent on certain financial criteria being met by the company, including a significant shareholder equity contribution, maintaining stock exchange listings, and meeting payment deadlines. Additionally, Marpai signed a deal with Libertas Funding LLC to sell $2.193 million in future receipts for $1.7 million, with terms including an early delivery discount and an origination fee, backed by a personal guarantee from CEO Damien Lamendola.
For further insights into MRAI stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.